Serum Ischemia-Modified Albumin, Fibrinogen, High Sensitivity C- Reactive Proteins in Type-2 Diabetes Mellitus without Hypertension and Diabetes Mellitus with Hypertension: A Case-Control Study | Zendy

Sushith Sushith | Zendy; Herijenahalli Nagaraju Krishnamurthy | Zendy; Shridhar Reshma | Zendy; Janice Dsa | Zendy; Gopal R Madan | Zendy; Ashok Kumar Jeppu | Zendy; Mangalore Balakrishna Prathima | Zendy; Bhuvanesh Sukhlal Kalal | Zendy

Open Access

Serum Ischemia-Modified Albumin, Fibrinogen, High Sensitivity C- Reactive Proteins in Type-2 Diabetes Mellitus without Hypertension and Diabetes Mellitus with Hypertension: A Case-Control Study

Author(s) -

Sushith Sushith,

Herijenahalli Nagaraju Krishnamurthy,

Shridhar Reshma,

Janice Dsa,

Gopal R Madan,

Ashok Kumar Jeppu,

Mangalore Balakrishna Prathima,

Bhuvanesh Sukhlal Kalal

Publication year - 2020

Publication title -

reports of biochemistry and molecular biology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.467

H-Index - 8

ISSN - 2322-3480

DOI - 10.29252/rbmb.9.2.241

Subject(s) - medicine , glycated hemoglobin , diabetes mellitus , endocrinology , body mass index , c reactive protein , type 2 diabetes mellitus , fibrinogen , creatinine , lipid profile , type 2 diabetes , inflammation

The objective of this study was to determine the levels of serum ischemia-modified albumin (IMA), fibrinogen (FIB) and high sensitivity C-reactive protein (hs-CRP) in type 2 diabetes mellitus (T2DM) patients with hypertension (HT) (DMT2HTN) and without HT (DMT2). Also, their association with certain biochemical and physical factors were studied to identify possible risk factors that lead to cardiovascular complications.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research